CRO space to see spate of M&As

MG Arun
Posted: Monday, Jun 23, 2008 at 0025 hrs IST
Updated: Monday, Jun 23, 2008 at 0025 hrs IST

Font Size

Feedback

Discuss

Bharti offers MTN $13.1 bn in cash Bharti, MTN extend merger talks again

Mumbai, Jun 22 : The Daiichi Sankyo — Ranbaxy deal may have set the tone for a large scale consolidation in the Indian pharmaceutical industry, but yet another crucial segment within life sciences is in for a shake-up, too. The Indian clinical research segment is all set to witness consolidation, with a few clinical research organisations (CROs) keen to sell out.

Sources say two CROs based in Mumbai and two in Hyderabad are on the block, and more are in the pipeline. Some bigger CROs are looking at merging with larger firms.

Post Comments

Comments: (Limit 3,000 characters)

Name		Message
Email ID
Subject

TERMS OF USE:
The views, opinions and comments posted are your, and are not endorsed by this website. You shall be solely responsible for the comment posted here. The website reserves the right to delete, reject, or otherwise remove any views, opinions and comments posted or part thereof. You shall ensure that the comment is not inflammatory, abusive, derogatory, defamatory &/or obscene, or contain pornographic matter and/or does not constitute hate mail, or violate privacy of any person (s) or breach confidentiality or otherwise is illegal, immoral or contrary to public policy. Nor should it contain anything infringing copyright &/or intellectual property rights of any person(s).

I agree to the terms of use.